Literature DB >> 15479995

Diagnosing ICD-10 depressive episodes: superior criterion validity of the Patient Health Questionnaire.

Bernd Löwe1, Kerstin Gräfe, Stephan Zipfel, Steffen Witte, Bernd Loerch, Wolfgang Herzog.   

Abstract

BACKGROUND: Diagnosing and monitoring depression in primary care remains an issue of significant public health concern. Clinicians and researchers need to know if any one screening instrument is superior to the others in diagnosing ICD-10 depressive episodes. This study aimed to examine the criterion validity for diagnosing ICD-10 depressive episodes of the Patient Health Questionnaire (PHQ) in comparison with 2 well-established instruments, the Hospital Anxiety and Depression Scale (HADS), and the WHO Well-Being Index 5 (WBI-5).
METHODS: Five hundred and one medical outpatients completed the questionnaires and had a clinical interview. The presence of a depressive episode was determined with the International Diagnostic Checklists (IDCL) for ICD-10 as the criterion standard. Coefficient kappa (kappa), sensitivities and specificities were calculated and a statistical comparison of the areas under the receiver operating characteristic curves was performed.
RESULTS: Diagnostic agreement between the questionnaires and the IDCL was moderate (kappa=0.34-0.56), with the highest values for the PHQ. While all 3 questionnaires had reasonable sensitivity and specificity, the operating characteristics for the PHQ were significantly superior to both the HADS and the WBI-5 (p=0.02).
CONCLUSIONS: Any of the 3 screening instruments can be recommended for clinical use. However, this is the first comparative study to demonstrate the diagnostic advantage of a particular depression-screening instrument using the ICD-10 diagnostic criteria. The superior criterion validity of the PHQ is likely attributable to its closer representation of the current concept of depressive disorders.

Entities:  

Mesh:

Year:  2004        PMID: 15479995     DOI: 10.1159/000080393

Source DB:  PubMed          Journal:  Psychother Psychosom        ISSN: 0033-3190            Impact factor:   17.659


  92 in total

1.  Inflammatory pathways link socioeconomic inequalities to white matter architecture.

Authors:  Peter J Gianaros; Anna L Marsland; Lei K Sheu; Kirk I Erickson; Timothy D Verstynen
Journal:  Cereb Cortex       Date:  2012-07-06       Impact factor: 5.357

2.  Test-retest reliability of an fMRI paradigm for studies of cardiovascular reactivity.

Authors:  Lei K Sheu; J Richard Jennings; Peter J Gianaros
Journal:  Psychophysiology       Date:  2012-05-17       Impact factor: 4.016

Review 3.  Depression, Anxiety, and Cognitive Impairment : Comorbid Mental Health Disorders in Heart Failure.

Authors:  Christiane E Angermann; Georg Ertl
Journal:  Curr Heart Fail Rep       Date:  2018-12

4.  Managing depression in home health care: a randomized clinical trial.

Authors:  Kathleen Ell; Jürgen Unützer; Maria Aranda; Nancy E Gibbs; Pey-Jiuan Lee; Bin Xie
Journal:  Home Health Care Serv Q       Date:  2007

5.  Randomized controlled trial of collaborative care management of depression among low-income patients with cancer.

Authors:  Kathleen Ell; Bin Xie; Brenda Quon; David I Quinn; Megan Dwight-Johnson; Pey-Jiuan Lee
Journal:  J Clin Oncol       Date:  2008-09-20       Impact factor: 44.544

6.  Preoperative depression symptom severity and its impact on adherence to preoperative beta-blocker therapy.

Authors:  Robert B Schonberger; Jessica Feinleib; Natalie Holt; Feng Dai; Cynthia Brandt; Matthew M Burg
Journal:  J Cardiothorac Vasc Anesth       Date:  2014-09-26       Impact factor: 2.628

Review 7.  [Chronic heart failure and depression].

Authors:  C Herrmann-Lingen
Journal:  Internist (Berl)       Date:  2018-05       Impact factor: 0.743

8.  Screening for depression in medical settings with the Patient Health Questionnaire (PHQ): a diagnostic meta-analysis.

Authors:  Simon Gilbody; David Richards; Stephen Brealey; Catherine Hewitt
Journal:  J Gen Intern Med       Date:  2007-09-14       Impact factor: 5.128

9.  Effects of perceived social status and discrimination on hope and empowerment among individuals with serious mental illnesses.

Authors:  Stephanie Langlois; Luca Pauselli; Simone Anderson; Oluwatoyin Ashekun; Samantha Ellis; JaShala Graves; Adria Zern; Ebony Gaffney; Ruth S Shim; Michael T Compton
Journal:  Psychiatry Res       Date:  2020-02-08       Impact factor: 3.222

10.  Screening for affective and anxiety disorders in medical patients - comparison of HADS, GHQ-12 and Brief-PHQ.

Authors:  Daniela Hahn; Katrin Reuter; Martin Härter
Journal:  Psychosoc Med       Date:  2006-12-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.